You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动 | 康臣药业(1681.HK)直线拉升涨超11% 2020年纯利同比大增524.9%
格隆汇 03-23 13:11
格隆汇3月23日丨康臣药业(1681.HK)午后直线拉升,现报3.71港元,大涨11.41%,最新总市值30亿港元。康臣药业今日午间公布2020年度业绩称,期内实现收入17.53亿元(人民币,下同),同比增长1.4%;公司权益股东应占溢利4.99亿元,同比增长524.9%,倘扣除去年非现金项目的商誉及无形资产减值3.2亿元影响,同比增长23.5%;每股基本盈利0.61元,宣派末期股息每股0.20港元。公告还称,2020年,公司利用自有资金不断回购股票,全年共计回购了4590.7万股股票,占回购前总股本约5.3%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account